In this study, we identified PLCD1 as a functional TSG downregulated by promoter CpG methylation in RCC, and it exerts tumor suppressor effects by blocking WNT/β-catenin and EGFR-FAK-ERK signaling. The gene discussed is PTK2; the disease is neoplasm.